HogenEsch, Harm http://orcid.org/0000-0002-2738-9189
O’Hagan, Derek T.
Fox, Christopher B. http://orcid.org/0000-0002-4644-2619
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1130379)
Article History
Received: 17 June 2018
Revised: 6 September 2018
Accepted: 11 September 2018
First Online: 10 October 2018
Competing interests
: H.H. has conducted research funded by ChemTrade and SPI Pharma in the past 5 years. D.T.O.H. is an employee of GlaxoSmithKline. C.B.F. is an inventor on patent applications involving combination TLR ligand-aluminum adjuvants and nanoparticle aluminum adjuvants.